| ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection A Hachim, N Kavian, CA Cohen, AWH Chin, DKW Chu, CKP Mok, ... Nature immunology 21 (10), 1293-1301, 2020 | 241 | 2020 |
| Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse A Servettaz, C Goulvestre, N Kavian, C Nicco, P Guilpain, C Chéreau, ... The Journal of Immunology 182 (9), 5855-5864, 2009 | 211 | 2009 |
| Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis A Servettaz, N Kavian, C Nicco, V Deveaux, C Chéreau, A Wang, ... The American journal of pathology 177 (1), 187-196, 2010 | 126 | 2010 |
| SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection CA Cohen, APY Li, A Hachim, DSC Hui, MYW Kwan, OTY Tsang, SS Chiu, ... Nature communications 12 (1), 4678, 2021 | 123 | 2021 |
| Targeting ADAM‐17/notch signaling abrogates the development of systemic sclerosis in a murine model N Kavian, A Servettaz, C Mongaret, A Wang, C Nicco, C Chéreau, ... Arthritis & Rheumatism 62 (11), 3477-3487, 2010 | 122 | 2010 |
| Dimethyl fumarate, a two‐edged drug: current status and future directions NEB Saidu, N Kavian, K Leroy, C Jacob, C Nicco, F Batteux, J Alexandre Medicinal research reviews 39 (5), 1923-1952, 2019 | 121 | 2019 |
| Sialylation levels of anti–proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's) C Espy, W Morelle, N Kavian, P Grange, C Goulvestre, V Viallon, ... Arthritis & Rheumatism 63 (7), 2105-2115, 2011 | 108 | 2011 |
| Trained immunity modulates inflammation-induced fibrosis M Jeljeli, LGC Riccio, L Doridot, C Chêne, C Nicco, S Chouzenoux, ... Nature communications 10 (1), 5670, 2019 | 103 | 2019 |
| Revised spectrum of mutations in sarcoglycanopathies M Trabelsi, N Kavian, F Daoud, V Commere, N Deburgrave, C Beugnet, ... European journal of human genetics 16 (7), 793-803, 2008 | 103 | 2008 |
| The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma N Kavian, S Mehlal, M Jeljeli, NEB Saidu, C Nicco, O Cerles, ... Frontiers in immunology 9, 1896, 2018 | 89 | 2018 |
| Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis P Guilpain, A Servettaz, C Goulvestre, S Barrieu, D Borderie, C Chéreau, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 75 | 2007 |
| Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature J Payet, J Livartowski, N Kavian, O Chandesris, N Dupin, N Wallet, ... Leukemia & lymphoma 54 (4), 767-777, 2013 | 68 | 2013 |
| Dimethyl fumarate controls the NRF2/DJ-1 axis in cancer cells: therapeutic applications NEB Saidu, G Noé, O Cerles, L Cabel, N Kavian-Tessler, S Chouzenoux, ... Molecular cancer therapeutics 16 (3), 529-539, 2017 | 67 | 2017 |
| New insights on chemically induced animal models of systemic sclerosis F Batteux, N Kavian, A Servettaz Current opinion in rheumatology 23 (6), 511-518, 2011 | 66 | 2011 |
| Suppl 1: new insights into the mechanism of notch signalling in fibrosis N Kavian, A Servettaz, B Weill, F Batteux The open rheumatology journal 6, 96, 2012 | 63 | 2012 |
| Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain C Wu, AJ Qavi, A Hachim, N Kavian, AR Cole, AB Moyle, ND Wagner, ... Iscience 24 (6), 2021 | 57 | 2021 |
| Reactive oxygen species–mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis N Kavian, W Marut, A Servettaz, C Nicco, C Chéreau, H Lemaréchal, ... Arthritis & Rheumatism 64 (10), 3430-3440, 2012 | 54 | 2012 |
| Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia–reperfusion injury H Hu, F Batteux, C Chéreau, N Kavian, W Marut, C Gobeaux, D Borderie, ... The Journal of pathology 225 (2), 265-275, 2011 | 50 | 2011 |
| Niclosamide inhibits oxaliplatin neurotoxicity while improving colorectal cancer therapeutic response O Cerles, E Benoit, C Chéreau, S Chouzenoux, F Morin, MA Guillaumot, ... Molecular cancer therapeutics 16 (2), 300-311, 2017 | 48 | 2017 |
| Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents JS Rosa Duque, X Wang, D Leung, SMS Cheng, CA Cohen, X Mu, ... nature communications 13 (1), 3700, 2022 | 47 | 2022 |
